Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
While injectable versions captured public and clinical attention with notable weight loss outcomes, oral options introduce a new level of convenience and patient accessibility
In addition to its role in diabetes management, liraglutide has been shown to promote weight loss in clinical studies, leading to its approval for obesity treatment under the brand name Saxenda
I.KwokS.BanerjeeA.PetraviczJ.WoodsonJ.et al (2014)
Cash-pay is now a real market in 2026, and the headline numbers are scattered: Wegovy tablets list a $149/month starter price, Zepbound vials list $299/month for the 2.5 mg starting dose, and a long tail of telehealth platforms publishes compounded semaglutide and tirzepatide pricing anywhere from sub-$150 first-month promos to $299/month standard
Off-ramp strategy
US$ 27.28
US$ 22.98
US$ 22.47
US$ 28.38
US$ 24.45
US$ 27.47
US$ 27.24
US$ 29.78
